![Jan Pinkas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Pinkas
Plus aucun poste en cours
Fortune : 459 235 $ au 31/05/2026
Profil
Jan Pinkas is Chief Scientific Officer at Crescent Biopharma, Inc. since 2025.
Former roles include Chief Scientific Officer at Pyxis Oncology, Inc. from 2022 to 2025, VP-Translational Research & Development at ImmunoGen, Inc., and Senior Vice President-Translation Services at Magenta Therapeutics, Inc. Education includes undergraduate studies at The Johns Hopkins University and a doctorate from the University of Massachusetts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,08% | 22/06/2026 | 22 239 ( 0,08% ) | 459 235 $ | 31/05/2026 |
Postes actifs de Jan Pinkas
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Jan Pinkas
| Sociétés | Poste | Fin |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/03/2025 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | - |
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Jan Pinkas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Choisissez Zonebourse 
